Roll over image to zoom in
Dasanat (Dasatinib) 50mg online
$269.00
Status: In stock
Dasatinib is a kinase inhibitor for adults with Philadelphia chromosome-positive chronic myeloid leukaemia in chronic phase when newly diagnosed, and for adults with chronic, accelerated, or myeloid or lymphoid blast phase disease who are resistant to or intolerant of prior therapy including imatinib. It is also used for adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia who are resistant to or intolerant of prior therapy.
Dasatinib is a kinase inhibitor indicated for the treatment of
- newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
- adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.
- adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
Related products
Recently Viewed Products
